SELFTACS
LIVE

Serial Number

98583034

Owner

Kesmalea Therapeutics Limited

Attorney

Stacy J. Grossman

Filing Date

Jun 4, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SELFTACS Trademark

Serial Number: 98583034 • Registration: 7896764

SELFTACS is a trademark filed by Kesmalea Therapeutics Limited on June 4, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Kesmalea Therapeutics Limited (2 trademarks)

8 Bloomsbury Street, 2nd Floor
London WC1B3SR , GB

Entity Type: 24

Trademark Details

Filing Date

June 4, 2024

Registration Date

August 19, 2025

Published for Opposition

June 3, 2025

Goods & Services

Scientific apparatus being spectrometers and parts and fittings therefor, research apparatus being nuclear medical research imaging apparatus, navigation apparatus being on-board computers for vehicles, surveying apparatus, photographic apparatus being cameras, cinematographic cameras, audiovisual receivers, optical readers, weighing machines, laser measuring systems, signalling whistles, radiation detecting apparatus, plastic testing machines, cameras for monitoring and inspecting equipment, life-saving rafts, and teaching apparatus and instruments, namely, artificial limbs for medical instruction purposes; recorded computer operating software; recorded computer operating software for use in scientific and pharmaceutical research and development; recorded computer software for scientific modelling; recorded computer software for pharmaceutical modelling; recorded computer software for data analysis and conducting research and development in the field of oncology, immunology and central nervous system disease; recorded computer software for the managing, analysis, and visualisation of biological data; devices for analysing protein sequence used as laboratory apparatus, namely, laboratory devices for detecting genetic sequences

Pharmaceutical preparations for oncology, immunology, viral infections, central nervous diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for the treatment of central nervous system diseases; biological preparations for medical use for the treatment of cancer, autoimmune diseases, viral infections, central nervous diseases; Pharmaceutical preparations for the treatment of cancer, viral infections, autoimmune diseases and central nervous diseases; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; protein synthesis inhibitors in the nature of antibiotics, none of the foregoing relating to preparations for the treatment of central nervous system diseases and disorders

Proteins for use in science; regulatory protein arrays for scientific and medical use

Medical services; medical analysis services relating to the treatment of patients; oral medical care services; medical diagnostic services; diagnostic and prognostic medical services; medical advisory services; medical screening; medical services in the field of oncology and immunotherapy; pharmacy advice, namely, prescription refill reminder services; medical and health clinic services relating to antibodies, immuno-oncology, inflammation, haematology, central nervous system and infectious disease

Surgical apparatus and instruments and medical imaging apparatus; medical devices for treatment of cancer, autoimmune diseases, viral infections and central nervous diseases; apparatus for drug administration, namely, disposable syringes; medical diagnostic apparatus for the detection of abnormal prion protein

Scientific laboratory services, medical research laboratory services; research relating to molecular sciences; blood analysis in the field of molecular biology for scientific research purposes; drug discovery services; clinical surgery research; medical research; biological research; medical research relating to pharmaceuticals; pharmaceutical research and development; development of pharmaceutical preparations and medicines; platform as a service (PaaS) featuring computer software platforms for data analysis; platform as a service (PaaS) featuring software platforms for medical analysis; software as a service (Saas) featuring software for assessing and storing patient information;  provision of temporary use of online, non-downloadable software for the management, visualisation and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; biotechnology research; scientific research and development in the pharmaceutical and biotechnology fields; chemical analysis; chemical research; medical research in the field of oncology, immunology and central nervous system diseases; research and development in the field of protein homeostasis; scientific research in the nature of conducting clinical trials for others

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 2, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 22, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 22, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 22, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 22, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 25, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 25, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 25, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 20, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 20, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2024 NWOS
NEW APPLICATION ENTERED
Jun 4, 2024 NWAP